Investor Relations rodneyhoganii September 10, 2024

Investor Relations

As a valued investor, this section serves as a comprehensive resource hub to provide you with up-to-date and relevant information about our company’s financial performance, strategic objectives, and overall investment proposition.

Template is not defined.


Thomas J. Shaw
Chairman, President, CEO

Michele M. Larios
Vice President and General Counsel

John W. Fort III
Vice President and CFO, Treasurer

Russell B. Kuhlman
Vice President, Sales Development

Kathryn M. Duesman
Vice President of Clinical Affairs

Lawrence G. Salerno
Director of Operations

R. John Maday
Production Manager

Jenny Margolis
Product Development Manager